---
title: CROs offering High-Throughput Screening with Biologics (Other)
path: /explore/high-throughput-screening/biologics-other
companies_count: 14
---

# CROs offering High-Throughput Screening with Biologics (Other)

14 published CROs match High-Throughput Screening and Biologics (Other).

Locations in this set include United States, China, India, United Kingdom, France, and Germany.

Capabilities that show up most often in this set: In Vitro Pharmacology, Discovery Research, In Vitro ADME / DMPK, In Vivo PK / PD Studies, and Medicinal Chemistry.

## Matching companies

- [Aragen Life Sciences](/companies/aragen)
  - Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
- [Aurigene Pharmaceutical Services Limited](/companies/aurigeneservices)
  - Integrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries.
- [BioDuro-Sundia](/companies/bioduro-sundia)
  - BioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission.
- [Certara](/companies/certara)
  - Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.
- [ChemPartner](/companies/chempartner)
  - Global preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide.
- [Creative Bioarray](/companies/creative-bioarray)
  - Creative Bioarray provides preclinical research solutions including drug screening, ADME-PK, toxicity studies, and cell-based services across oncology, neurology, cardiovascular, and metabolic therapeutic areas.
- [Eurofins Discovery](/companies/eurofinsdiscovery)
  - Eurofins Discovery provides comprehensive drug discovery CRO services across small molecules and biotherapeutics, with over 40 years of industry experience and a portfolio of 23,000+ services and products supporting discovery through development.
- [Nuvisan](/companies/nuvisan)
  - Full-service CRO and CDMO with specialized competency centers in drug discovery, formulation development, GMP manufacturing, and bioanalytical services across Germany and France.
- [Oncodesign Services](/companies/oncodesign-services)
  - Contract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Reaction Biology](/companies/reactionbiology)
  - Global preclinical CRO specializing in kinase drug discovery, cell-based assays, in vivo pharmacology, and immuno-oncology with 1,000+ cell lines and hundreds of validated protein targets across US and EU facilities.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [Tigermed](/companies/tigermedgrp)
  - Leading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
- [WuXi AppTec](/companies/wuxiapptec)
  - Global CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.